Spinal cord stimulator · St. Louis
Spinal cord stimulator in St. Louis, always after a trial
A spinal cord stimulator at Padda Institute in St. Louis always starts with a temporary trial. Thin leads are worn for several days of normal life, and only a clear drop in pain with better function earns a permanent implant. It is for nerve pain that injections, medication or surgery did not resolve.
A spinal cord stimulator is a thin lead placed in the epidural space, the layer just outside the spinal cord, wired to a small generator under the skin. Its mild electrical pulses change how nerve pain is processed on the way to the brain. It does not repair the injury that started the pain. It changes what the spinal cord reports, not what happened to the tissue.
No scan or exam can predict whether your nervous system will respond. So nobody at Padda Institute gets a permanent stimulator without first living with a temporary one, the same order that 2023 consensus guidelines on patient selection recommend. The trial is a test, not a smaller dose of treatment, and one of its most useful answers is no.
Who is a spinal cord stimulator for?
Nerve pain that outlasted the work done to fix it: burning or electric pain along a nerve's path that persisted through documented physical therapy, medication trials and targeted injections such as an epidural steroid injection, and sometimes surgery.
- Leg pain that persists after spine surgery, the best-proven use. The surgery did its mechanical job; the injured nerve root kept firing anyway.
- Complex regional pain syndrome (RSD), after blocks, ketamine and graded rehab, the sequence on the CRPS and RSD treatment page.
- Long-standing radicular or other nerve pain in an arm, a leg or the back that injections have not settled.
Screening keeps you from an implant that cannot help. It is the wrong tool for:
- A mechanical low back ache with no nerve component; the back pain page covers finding that generator.
- Widespread pain from altered pain processing with no regional target. No lead can reach pain that has no address.
- A structural problem surgery could still correct.
- An untreated infection, an uncorrected bleeding risk, or difficulty operating the device.
Leg pain that was never worked up belongs on the sciatica page before anyone mentions hardware.
What does the trial actually test?
Under live X-ray, a needle enters the epidural space between two vertebrae, and thin leads are threaded through the skin up to the lower mid-back levels for back and leg pain. The leads exit through the skin and stay for several days of normal routine while you log pain and function; dressings stay dry, so no showering. The trial and a later implant are both outpatient, home the same day.
A trial is only as clear as its definition. Settle these before the leads go in:
- What counts as success? A specific drop in pain, agreed in advance and measured against your log, not memory.
- Which function is tracked? Walking distance, standing time, sleep.
- What does a partial response mean? Reprogramming, a new target, or another treatment altogether.
- Which risks get fixed first? Smoking, untreated depression and heavy opioid use predict later device removal; fix them before booking.
The trial is still an epidural procedure, with exit-site infection, dural puncture and bleeding among its risks. If pain and function do not both clearly improve, the leads come out in the office and nothing is implanted. Every published outcome comes from people who first passed a trial; skip the trial and those numbers no longer apply to you.
What happens between a good trial and the implant?
Paperwork, screening and usually several weeks.
A psychological evaluation. The practice requires one before any permanent implantable device, the 2023 selection guidelines call for a validated screen that includes depression, and most insurers require it before approving the trial. It does not test whether the pain is genuine. Depression, anxiety or substance use left untreated lowers the odds that stimulation works, so they are treated first, in-house, by the practice's pain-trained psychologist.
Prior authorization. Insurers want documented failed conservative care, matching imaging, nerve testing or block results where relevant, the psychological evaluation and a written trial result. The office assembles that package, checks benefits before the trial and tells you where approval stands. Approval is still not a promise of payment.
The implant. Permanent leads go in the epidural space and the generator in a small pocket under the skin. Both the trial and the implant are done in-house by Dr. Gurpreet Singh Padda, MD, MBA, MHP, who is licensed as a physician and surgeon, holds surgical privileges, and has board certification in anesthesiology, pain medicine and interventional pain management.
Does a spinal cord stimulator work?
For the right patient, yes. Each number below comes with the group it describes.
- After spine surgery: the multicenter PROCESS trial, published in 2007, randomized people with failed back surgery syndrome to stimulation or standard medical care, and its 2008 follow-up showed the benefit still holding at twenty-four months.
- A 2025 review of 505 consecutive trials at one pain center (average age 67.5, 64 percent women): 86.1 percent passed the trial and 77.0 percent chose an implant. At 3 to 34 months, 76.6 percent of implanted patients kept significant improvement; 14.1 percent of devices were removed, most often because they stopped working well.
- Closed-loop systems, which record the nerve's response to each pulse and correct the next one as the cord shifts with posture and breathing: in the double-blind Evoke trial in back and leg pain, 83.1 percent reached at least 50 percent relief without more pain medication at twelve months, against 61.0 percent on a standard system. There was no placebo arm; both groups were stimulated.
- Chronic low back pain: a 2023 Cochrane review pooling 13 trials with 699 participants judged that stimulation probably fails to give lasting benefit large enough to outweigh its costs and risks in that group. The practice's answer is stricter selection: write down whether the pain is neuropathic or mechanical, and make the trial earn the implant.
The evidence is strongest where pain is clearly neuropathic and confined to a region.
Could a smaller device do the job?
Match the device to how far the pain spreads.
- Spinal cord stimulation covers wide territory: a whole limb, or the low back and both legs, because the lead sits where many nerve pathways converge.
- Peripheral nerve stimulation puts a fine lead beside one nerve you can name, after a diagnostic block proves that nerve carries the pain. No sedation, so your feedback guides placement; you drive home with no activity restrictions. A sixty-day percutaneous system is worn, then withdrawn in the office, leaving no implant; no baths or swimming while it is in. In RESET, an unblinded randomized trial of 230 people with low back pain, 55 percent reached at least 50 percent relief at three months, against 26 percent with usual care; people with radiating leg pain or prior lumbar surgery were excluded.
- The NS-100 is an FDA-cleared, Class II programmable stimulator for painful diabetic neuropathy that reaches the vagal pathway through the auricular nerve branches at the ear. Wear time runs as long as 30 days, roughly 20 for most people; placement needs no sedation and imposes no activity limits.
Can a stimulator help me come down on opioids?
It can carry part of the load: in a taper, procedures take over the medication's work so the dose can drop without withdrawal, and stimulation is one of them. In the 505-trial series, opioid use fell in 58.9 percent of patients. Chronic opioid use also predicted later removal, alongside tobacco, depression and falls after implant, so work on the dose belongs before the trial. The goal is a lower dose planned with your prescriber, not a switch the device flips. How tapering is run here is on the opioid tapering page.
What can go wrong, and what is life with one like?
The risks, plainly:
- Lead migration, the most common problem; reprogramming usually fixes it, and sometimes it needs a revision.
- Generator-pocket infection, uncommon but the top reason a system comes out.
- Dural puncture, which can leave a headache that worsens upright and eases lying down.
- Rarely, a bleed or abscess near the cord. A bleed pressing on the cord can cause permanent weakness unless relieved surgically within hours.
- Fading effect, revision surgery and limits on future MRI scans.
Carry the device card for imaging centers and airport metal detectors. Follow your device's instructions on stimulation while driving. You recharge the generator on a schedule, or, once its battery is spent, it is swapped out in a minor outpatient procedure. Reprogramming as pain changes is routine. If the device stops helping, the whole system can be removed.
Where does surgery fit?
Late. Conservative and interventional care are tried first; once they are exhausted, the practice performs implants of stimulators and intrathecal pumps, nerve decompression and microdiscectomy. A pump delivers medication into the fluid around the spinal cord and, like a stimulator, requires psychological screening first. Dr. Padda's published research includes multicenter studies of intrathecal drug delivery in Pain Medicine and Neuromodulation.
An implant is still a bridge. Muscle wasted by years of guarding returns through loading in physical therapy, not current. Incisions heal better with blood sugar controlled, so glucose is part of the procedure plan; sleep, food and in-house counseling run alongside the device.
How do I start?
Evaluations take place at 4477 Woodson Rd, Suite 100, St. Louis, MO 63134, next to Lambert Airport, or at the second office, 12174 Natural Bridge Rd, St. Louis, MO 63044. Phone (314) 481-5000 or text (314) 886-5902, Monday through Friday from 8 AM to 5 PM; online booking is on the schedule page. Bring imaging, surgical reports and a list of treatments already tried. Medicare and most major private insurers are accepted for stimulator care, and the office confirms your benefits before a trial date is set. The Woodson office does not take Medicaid as primary coverage, and marketplace plans seldom pay for advanced treatment here.
Sudden leg weakness, a fever with severe back pain, or newly losing control of bladder or bowel means calling 911, including in the days after a stimulator procedure.
Frequently asked questions
What is neurostimulation therapy?
Neurostimulation uses small electrical pulses to change how a nerve or the spinal cord handles pain, without destroying tissue. Spinal cord stimulation works across a broad region, peripheral nerve stimulation works on one nerve, and the NS-100 works through the vagal branches at the ear. The ear-based option for diabetic nerve pain is described on the peripheral neuropathy page.
Will I feel the stimulator?
That depends on the waveform. Some programs produce a light tingling over the painful area; high-frequency and burst programs work below the level of sensation. Modern systems carry several waveforms in case the first program does not suit you, and the settings are adjusted as your pain changes. You can talk through which fits at your first visit.
Is pain normal after a spinal cord stimulator implant?
Soreness at the generator pocket is common at first, especially in thin patients. Signs of infection, a headache that changes with position, or new leg weakness are not routine, and weakness means 911. The full procedure menu is on the interventional pain management page.
Can I have an MRI with a spinal cord stimulator?
Many current systems are MRI-conditional, meaning scans are possible under conditions the manufacturer sets for that system and body part. Tell the imaging center which system you have, card in hand, when the scan is scheduled. Those limits are part of the conversation before your trial. Why a spine scan is read against your exam rather than on its own is covered on the back pain page.
What happens if my stimulator trial does not work?
The leads come out in the office, nothing is implanted, and the plan moves to other targets. That may mean nerve blocks, peripheral nerve stimulation aimed at a single nerve, or another epidural steroid injection where an inflamed nerve root is still the driver. A failed trial still answered its question.
Does insurance cover a spinal cord stimulator?
It is usually a covered benefit once the documentation rules are met. Those rules nearly always mean prior authorization plus four items: proof that conservative care failed, imaging that fits the symptoms, a completed psychological evaluation and a trial that succeeded. Coverage and your share vary by plan, so benefits are checked before the trial, and an authorization never promises payment. The conservative treatments insurers expect to see first are on the non-opioid pain treatment page.
Sources
- Shanthanna H, Eldabe S, Provenzano DA, et al. (2023). Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain. Regional Anesthesia and Pain Medicine, 48(6):273-287. doi:10.1136/rapm-2022-104097 PMID: 37001888.
- Kumar K, Taylor RS, Jacques L, et al. (2007). Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain, 132(1-2):179-188. doi:10.1016/j.pain.2007.07.028 PMID: 17845835.
- Kumar K, Taylor RS, Jacques L, et al. (2008). The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery, 63(4):762-770. doi:10.1227/01.NEU.0000325731.46702.D9 PMID: 18981888.
- Gheith R, Wortmann M, Najjar M, et al. (2025). Real-World Outcomes of Spinal Cord Stimulation: A Consecutive Institutional Experience with 505 Trials, Trial-to-Implant Ratio, Long-Term Efficacy, and Explantation Risk Factors. Journal of Pain Research, 18:6381-6395. doi:10.2147/JPR.S552361 PMID: 41341898.
- Mekhail N, Levy RM, Deer TR, et al. (2020). Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. The Lancet Neurology, 19(2):123-134. doi:10.1016/S1474-4422(19)30414-4 PMID: 31870766.
- Traeger AC, Gilbert SE, Harris IA, et al. (2023). Spinal cord stimulation for low back pain. Cochrane Database of Systematic Reviews, 3(3):CD014789. doi:10.1002/14651858.CD014789.pub2 PMID: 36878313.
- McCormick ZL, Lester DD, DePalma MJ, et al. (2026). Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain-a multicenter pragmatic randomized controlled trial (RESET). Pain Medicine, 27(4):462-473. doi:10.1093/pm/pnaf147 PMID: 41138174.
- Rauck R, Deer T, Rosen S, et al. (2010). Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra(®) Programmable Pump. Neuromodulation, 13(2):102-108. doi:10.1111/j.1525-1403.2009.00257.x PMID: 21992782.
- Rauck R, Deer T, Rosen S, et al. (2013). Long-term follow-up of a novel implantable programmable infusion pump. Neuromodulation, 16(2):163-167. doi:10.1111/j.1525-1403.2012.00515.x PMID: 23057877.
- Rosen SM, Bromberg TA, Padda G, et al. (2013). Intrathecal administration of Infumorph® vs compounded morphine for treatment of intractable pain using the Prometra® programmable pump. Pain Medicine, 14(6):865-873. doi:10.1111/pme.12077 PMID: 23570280.